156 related articles for article (PubMed ID: 27507614)
21. Roles of fibroblast growth factor-inducible 14 in hepatocellular carcinoma.
Li N; Hu WJ; Shi J; Xue J; Guo WX; Zhang Y; Guan DX; Liu SP; Cheng YQ; Wu MC; Xie D; Liu SR; Cheng SQ
Asian Pac J Cancer Prev; 2013; 14(6):3509-14. PubMed ID: 23886137
[TBL] [Abstract][Full Text] [Related]
22. S100A14 promotes the growth and metastasis of hepatocellular carcinoma.
Zhao FT; Jia ZS; Yang Q; Song L; Jiang XJ
Asian Pac J Cancer Prev; 2013; 14(6):3831-6. PubMed ID: 23886191
[TBL] [Abstract][Full Text] [Related]
23. Glycyrrhiza polysaccharide induces apoptosis and inhibits proliferation of human hepatocellular carcinoma cells by blocking PI3K/AKT signal pathway.
Chen J; Jin X; Chen J; Liu C
Tumour Biol; 2013 Jun; 34(3):1381-9. PubMed ID: 23580179
[TBL] [Abstract][Full Text] [Related]
24. Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone.
Gao YB; Xiang ZL; Zhou LY; Wu ZF; Fan J; Zeng HY; Zeng ZC
J Cancer Res Clin Oncol; 2013 Apr; 139(4):669-79. PubMed ID: 23307318
[TBL] [Abstract][Full Text] [Related]
25. [Expression of centromere protein A in hepatocellular carcinoma].
Li YM; Liu XH; Cao XZ; Wang L; Zhu MH
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):175-8. PubMed ID: 17535684
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.
Zhang G; Liu T; Wang Z
J Invest Surg; 2012 Apr; 25(2):93-9. PubMed ID: 21942217
[TBL] [Abstract][Full Text] [Related]
27. Involvement of hepatopoietin Cn in the development of human hepatocellular carcinoma.
Zhu BD; Li XL; Liu Y; Chang J; Liu Y; Zhang DD; Wang Q; Ren J; Cui CP
Clin Exp Metastasis; 2010 Dec; 27(8):571-80. PubMed ID: 20683644
[TBL] [Abstract][Full Text] [Related]
28. MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation.
Cai X; Gao J; Yan Z; Zhang H; Guo D; Zhang S
J Cancer Res Clin Oncol; 2024 Jun; 150(6):303. PubMed ID: 38861187
[TBL] [Abstract][Full Text] [Related]
29. Decreased levels of nitric oxide production and nitric oxide synthase-2 expression are associated with the development and metastasis of hepatocellular carcinoma.
Zhou L; Wang Y; Tian DA; Yang J; Yang YZ
Mol Med Rep; 2012 Dec; 6(6):1261-6. PubMed ID: 23007408
[TBL] [Abstract][Full Text] [Related]
30. Over-expression of Na+/H+ exchanger 1 and its clinicopathologic significance in hepatocellular carcinoma.
Yang X; Wang D; Dong W; Song Z; Dou K
Med Oncol; 2010 Dec; 27(4):1109-13. PubMed ID: 19876777
[TBL] [Abstract][Full Text] [Related]
31. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.
Jing Z; Nan KJ; Hu ML
World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979
[TBL] [Abstract][Full Text] [Related]
32. Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53.
Hagiwara S; Kudo M; Nakatani T; Sakaguchi Y; Nagashima M; Fukuta N; Kimura M; Hayakawa S; Munakata H
Br J Cancer; 2007 Dec; 97(11):1532-7. PubMed ID: 17971768
[TBL] [Abstract][Full Text] [Related]
33. Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma.
Ikeguchi M; Ueda T; Sakatani T; Hirooka Y; Kaibara N
Diagn Mol Pathol; 2002 Mar; 11(1):33-40. PubMed ID: 11854600
[TBL] [Abstract][Full Text] [Related]
34. Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma.
Zhang MF; Zhang ZY; Fu J; Yang YF; Yun JP
J Transl Med; 2009 Dec; 7():110. PubMed ID: 20025780
[TBL] [Abstract][Full Text] [Related]
35. Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing.
Gao S; Yang Z; Zheng ZY; Yao J; Zhang F; Wu LM; Xie HY; Zhou L; Zheng SS
World J Surg Oncol; 2013 Mar; 11():57. PubMed ID: 23496880
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.
Zhang S; Wang Y; Dai SD; Wang EH
BMC Cancer; 2011 May; 11():186. PubMed ID: 21599923
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis in hepatocellular carcinoma Smmc-7721 cells by vitamin K(2) is associated with p53 and independent of the intrinsic apoptotic pathway.
Li L; Qi Z; Qian J; Bi F; Lv J; Xu L; Zhang L; Chen H; Jia R
Mol Cell Biochem; 2010 Sep; 342(1-2):125-31. PubMed ID: 20449638
[TBL] [Abstract][Full Text] [Related]
38. Role of the pituitary tumor transforming gene 1 in the progression of hepatocellular carcinoma.
Liang M; Chen X; Liu W; Li S; Li C; Jiang L; Lv S
Cancer Biol Ther; 2011 Feb; 11(3):337-45. PubMed ID: 21099350
[TBL] [Abstract][Full Text] [Related]
39. Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma.
Lee YH; Andersen JB; Song HT; Judge AD; Seo D; Ishikawa T; Marquardt JU; Kitade M; Durkin ME; Raggi C; Woo HG; Conner EA; Avital I; Maclachlan I; Factor VM; Thorgeirsson SS
Cancer Res; 2010 Nov; 70(21):8264-9. PubMed ID: 20959491
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
Chao X; Zhang W; Wu J; Feng X; Shi H; Zhao L; Shen H; Jiang C
Biomed Res Int; 2021; 2021():1971048. PubMed ID: 34485511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
